Back
United Therapeutics Stock Price Chart
"This Changes Everything" - Trump Hands Millions Massive IRS Gift
Learn More Here
Sell
50
UTHR
United Therapeutics
Last Price:
365.08
Seasonality Move:
10.82%
7 Day Trial
ALL ACCESS PASS
$
7
Invest. Do Good. Get Rewarded. Just $0.25/Share!
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.- Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and UTHR is experiencing buying pressure, which is a positive indicator for future bullish movement.
United Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 379.48 | Sell |
| 20-day SMA: | 375.79 | Sell |
| 50-day SMA: | 363.31 | Buy |
| 200-day SMA: | 300.12 | Buy |
| 8-day EMA: | 373.36 | Sell |
| 20-day EMA: | 374.93 | Sell |
| 50-day EMA: | 364.61 | Sell |
| 200-day EMA: | 314.85 | Buy |
United Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 2.54 | Buy |
| Relative Strength Index (14 RSI): | 44.48 | Sell |
| Chaikin Money Flow: | 110184 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (355.36 - 392.44) | Sell |
| Bollinger Bands (100): | (327.49 - 369.99) | Buy |
United Therapeutics Technical Analysis
| Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 07 | 08 | 11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for United Therapeutics Stock
Is United Therapeutics Stock a Buy?
- United Therapeutics share price is 364.33 while UTHR 8-day simple moving average is 379.48, which is a Sell signal.
- The stock price of UTHR is 364.33 while United Therapeutics 20-day SMA is 375.79, which makes it a Sell.
- United Therapeutics 50-day simple moving average is 363.31 while UTHR share price is 364.33, making it a Buy technically.
- UTHR stock price is 364.33 and United Therapeutics 200-day simple moving average is 300.12, creating a Buy signal.
UTHR Technical Analysis vs Fundamental Analysis
Sell
50
United Therapeutics (UTHR)
is a Sell
Is United Therapeutics a Buy or a Sell?
-
United Therapeutics stock is rated a Sell
The current United Therapeutics [UTHR] share price is $364.33. The Score for UTHR is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.
United Therapeutics Stock Info
Market Cap:
16.27B
Price in USD:
364.33
Share Volume:
192.44K
United Therapeutics 52-Week Range
52-Week High:
417.82
52-Week Low:
208.62
Sell
50
United Therapeutics (UTHR)
is a Sell
United Therapeutics Share Price Forecast
-
What is the United Therapeutics stock price today?
The United Therapeutics stock price is 364.33 USD today. -
Will UTHR stock go up or go down?
United Therapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is United Therapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, United Therapeutics is overvalued.
Is United Therapeutics Stock a Buy?
- United Therapeutics share price is 364.33 while UTHR 8-day exponential moving average is 373.36, which is a Sell signal.
- The stock price of UTHR is 364.33 while United Therapeutics 20-day EMA is 374.93, which makes it a Sell.
- United Therapeutics 50-day exponential moving average is 364.61 while UTHR share price is 364.33, making it a Sell technically.
- UTHR stock price is 364.33 and United Therapeutics 200-day simple moving average is 314.85, creating a Buy signal.
Fundamental Analysis of United Therapeutics
Is United Therapeutics a good investment?
- Analysts estimate an earnings increase this quarter of $1.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $6.10 per share, and an increase next year of $2.37 per share.
Technical Analysis of United Therapeutics
Should I short United Therapeutics stock?
- UTHR Moving Average Covergence Divergence (MACD) indicator is 2.54, suggesting United Therapeutics is a Buy
- United Therapeutics Relative Strength Index (RSI) is 44.48, which suggest United Therapeutics is oversold
- The Bollinger Bands (25) for United Therapeutics is (355.36 - 392.44), which suggest United Therapeutics is a Buy
- The Bollinger Bands (100) for United Therapeutics is (327.49 - 369.99), which suggest United Therapeutics is a Buy
* United Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.